34th Workshop of the European Helicobacter and Microbiota Study Group
September 18, 2021
EHMSG 2021 has been accredited with 8 European CME credits
EHMSG 2021 Virtual Conference | Live Sessions
PROGRAMME
SATURDAY, SEPTEMBER 18, 2021
All times are Central European Summer Time (CEST)
08.00 – 08.15 Session 1 - Welcome and introduction
1.1 - Welcome and introduction
Mirjana Rajilic Stojanovic & Tomica Milosavljevic
08.15 – 08.35 Session 2 - Introductory lecture
Chair: Francis Mégraud, Leif Andersen
2.1 - A tribute to Samy Cadranel: H. pylori infection in Pediatrics beginning in Brussels
Patrick Bontems (Brussels, Belgium)
08.35 - 09.35 Session 3 - Gastric carcinogenesis symposium
Chair: José Machado, Jae Gyu Kim
08.35 – 08.55
3.1 - Quiescent stem cells: differentiated cells reprogram to fuel repair, metaplasia and neoplasia in the adult stomach
Jason C Mills (St Louis, MI, USA)
08.55 – 09.15
3.2 - The hippo pathway in gastric carcinogenesis
Christine Varon (Bordeaux, France)
09.15 – 09.35
3.3 - Extracellular vesicles from cancer-associated fibroblasts induce drug resistance
Takatsugu Ishimoto (Kumamoto, Japan)
09.35 - 09.45 Break
09.45 - 11.05 Session 4 - Gastric cancer symposium
Chair: Peter Malfertheiner, Theodore Rokkas
09.45 – 10.05
4.1 - Autoimmune gastritis and risk of GC
Christian Abnet (Rockville, MD, USA)
10.05 – 10.25
4.2 - How to follow patients with gastric premalignant lesions
Tamara Matysiak Budnik (Nantes, France)
10.25 – 10.45
4.3 - Mistakes in GC screening
Marcis Leja (Riga, Latvia)
10.45 – 11.05
4.4 - Elimination of GC related deaths in Japan
Mototsugu Kato (Hakadate, Japan)
11.05 - 12.05 Session 5 - Satellite Symposium
(click HERE to view the detailed programme)
12.05 – 13.00 Lunch Break & Poster Viewing
13.00 - 13.15 Session 6 - Awarding of the Marshall & Warren Medal
Chair: Francis Mégraud, Mirjana Rajilic Stojanovic
6.1 - Dulciene Queiroz (Belo Horizonte, Brazil)
13.15 – 14.35 Session 7 - H. pylori treatment symposium
Chair: Colm O’Morain, Tomica Milosavljevic
13.15 – 13.35
7.1 - Pathways of antimicrobial resistance through data sciences
Niyaz Ahmed (Hyderabad, India)
13.35 – 13.55
7.2 - The Korean registry on H. pylori eradication (Koreg): Transition in therapy
Joon Sung Kim (Seoul, Korea)
13.55 – 14.15
7.3 - What we have learned from the European H. pylori registry (HpEuReg)
Javier Gisbert (Madrid, Spain)
14.15 – 14.35
7.4 - Role of meta-analysis of H. pylori in the era of antimicrobial stewardship
David Graham (Houston, TX, USA)
14.35 – 14.45 Break
14.45 – 16.25 Session 8 - Microbiota Symposium
Chair: Annemieke Smet, Antonio Gasbarrini
14.45 – 15.05
8.1 - Gastric microbiota changes during gastric carcinogenesis as a diagnostic biomarker
Jae Yong Park (Seoul, Korea)
15.05 – 15.25
8.2 - Correlation of microbiota composition and COVID immunity
Mirjana Rajilic Stojanovic (Belgrade, Serbia)
15.25 – 15.45
8.3 - Million microbiome from humans project, MMHP
Lars Engstrand (Stockholm, Sweden)
15.45 – 16.05
8.4 - How gut microbiota alters the brain
Gerard Clarke (Cork, Ireland)
16.05 – 16.25
8.5 - Microbiota in NAFLD/MAFLD
Herbert Tilg (Innsbruck, Austria)
16.25 – 16.40 Break
16.40 – 18.00 Session 9 - FMT symposium
Chair: Georgina Hold, Herbert Tilg
16.40 – 17.00
9.1 - FMT in the COVID era
Josbert Keller (The Hague, The Netherlands)
17.00 – 17.20
9.2 - COVID risk during endoscopy and FMT
Gianluca Ianiro (Rome, Italy)
17.20 – 17.40
9.3 - FMT for IBD
Sam Costello (Adelaide, Australia)
17.40 – 18.00
9.4 - FMT to newborns
Katri Korpela (Helsinki, Finland)
18.00 – 18.30 Session 10 - Debate: Tools for modulating gut microbiota function, probiotics vs. prebiotics
Chair: Lars Engstrand, Josbert Keller
18.00 – 18.15
• 10.1 - Benefit of Prebiotics
Petia Petkova Datchary, Würzburg, Germany
18.15 – 18.30
• 10.2 - Benefit of Probiotics
Muriel Derrien, Palaiseau, France
18.30 – 19.00 Session 11 - Closing Session
Chair: Mirjana Rajilic Stojanovic, Georgina Hold
18.30 – 18.40
11.1 - Poster Awards
18.40 – 19.00
11.2 - Presentation of the Workshop 2022 in Glasgow, United Kingdom
Georgina Hold (Sydney, Australia)
